Novel treatments for congenital adrenal hyperplasia

Patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21OHD) need life-long medical treatment to replace the lacking glucocorticoids and potentially lacking mineralocorticoids and to lower elevated adrenal androgens. Long-term complications are common, including gona...

Descripción completa

Detalles Bibliográficos
Autores principales: Schröder, Mariska A. M., Claahsen - van der Grinten, Hedi L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156475/
https://www.ncbi.nlm.nih.gov/pubmed/35199280
http://dx.doi.org/10.1007/s11154-022-09717-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156475/
https://www.ncbi.nlm.nih.gov/pubmed/35199280
http://dx.doi.org/10.1007/s11154-022-09717-w

Ejemplares similares